Micronutrient antioxidants and smoking

British Medical Bulletin

Volumn 55, Issue 3, 1999, Pages 691-704

  Cross, Carroll E ^a,d   Traber, Maret ^b   Eiserich, Jason ^c   Van Der Vliet, Albert ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OREGON STATE UNIVERSITY   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CANNABIS; CIGARETTE SMOKE; TRACE ELEMENT;

ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; DIETARY INTAKE; FRUIT; HUMAN; IMMUNE SYSTEM; LUNG CANCER; OXIDATIVE STRESS; PASSIVE SMOKING; PRIORITY JOURNAL; REVIEW; VEGETABLE;

EID: 0032711036     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1258/0007142991902565     Document Type: Review

References (94)

1. A report of the Surgeon General. Reducing the Health Consequences of Smoking: 25 Years of Progress. Rockville, MD: US Department of Health and Human Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 1989
2. Sauberlich H, Machlin L (Eds) Beyond Deficiency: New Views On The Function and Health Effects of Vitamins. New York, NY: Ann NY Acad Sci, 1992
3. Diana J, Pryor W (Eds) Tobacco Smoking and Nutrition: Influence of Nutrition on Tobacco - Associated Health Risks. New York, NY: Ann NY Acad Sci, 1993
4. Dallongeville J, Marecaux N, Fruchart JC, Amouyel P. Cigarette smoking is associated with unhealthy patterns of nutrient intake: a meta-analysis. J Nutr 1998; 128: 1450-7
5. Kallner AB, Hartmann D, Hornig DH. On the requirements of ascorbic acid in man: steady-state turnover and body pool in smokers. Am J Clin Nutr 1981; 34: 1347-55
6. Lykkesfeldt J, Loft S, Nielsen JB, Poulsen HE. Ascorbic acid and dehydroascorbic acid as biomarkers of oxidative stress caused by smoking. Am J Clin Nutr 1997; 65: 959-63
7. Munro LH, Burton G, Kelly FJ. Plasma RRR-alpha-tocopherol concentrations are lower in smokers than in non-smokers after ingestion of a similar oral load of this antioxidant vitamin. Clin Sci 1997; 92: 87-93
8. Eiserich JP, van der Vliet A, Handleman GJ, Halliwell B, Cross CE. Dietary antioxidants and cigarette smoke-induced biomolecular damage: a complex interaction. Am J Clin Nutr 1995; 62 (Suppl 6): 1490S-500S
9. Pryor W. Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity. Enrviron Health Perspect 1997; 105 (Suppl 4): 875-82
10. Steinberg D. Lewis A. Connor memorial lecture. Oxidative modification of LDL and atherogenesis. Circulation 1997; 95: 1062-71
11. Diaz MN, Frei B, Vita JA, Keaney Jr JF. Antioxidants and atherosclerotic heart disease. N Engl J Med 1997; 337: 408-16
12. Schwenke DC. Antioxidants and atherogenesis. J Nutr Biochem 1998; 9: 424-45
13. Diplock AT, Charleux JL, Crozier-Willi G et al. Functional food science and defense against reactive oxidative species. Br J Nutr 1998; 80 (Suppl 1): S77-112
14. Hampton MB, Kettle AJ, Winterbourn CC. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 1998; 92: 3007-17
15. Elneihoum AM, Falke P, Hedblad B, Lindgarde F, Ohlsson K. Leukocyte activation in atherosclerosis: correlation with risk factors. Atherosclerosis 1997; 131: 79-84
16. Dong ZM, Wagner DD. Leukocyte-endothelium adhesion molecules in atherosclerosis. J Lab Clin Med 1998; 132: 369-75
17. Lehr HA, Kress E, Menger MD et al. Cigarette smoke elicits leukocyte adhesion to endothelium in hamsters inhibition by CuZn-SOD. Free Radic Biol Med 1993; 14: 573-81
18. Lehr HA, Frei B, Arfors KE. Vitamin C prevents cigarette smoke-induced leukocyte aggregation and adhesion to endothelium in vivo. Proc Natl Acad Sci USA 1994; 91: 7688-92
19. Weber C, Erl W, Weber K, Weber PC. Increased adhesiveness of isolated monocytes to endothelium is prevented by vitamin C intake in smokers. Circulation 1996; 93: 1488-92
20. Lehr HA, Weyrich AS, Saetzler RK et al. Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking. J Clin Invest 1997; 99: 2358-64
21. Cachia O, El Benna J, Pedruzzi E et al. Alpha-tocopherol inhibits the respiratory burst in human monocytes: attenuation of p47(phox) membrane translocation and phosphorylation. J Biol Chem, 1998; 273: 32801-5
22. Hunt BJ, Jurd KM. Endothelial cell activation. A central pathophysiological process. BMJ 1998; 316: 1328-9
23. Cines DB, Pollak ES, Buck CA et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998; 91: 3527-61
24. Celermajer DS. Endothelial dysfunction: does it matter? Is it reversible? J Am Coll Cardiol 1997; 30: 325-33
25. Maxwell AJ, Tsao PS, Cooke JP. Modulation of the nitric oxide synthase pathway in atherosclerosis. Exp Physiol 1998; 83: 573-84
26. Toutouzas PC, Tousoulis D, Davies GJ. Nitric oxide synthesis in atherosclerosis. Eur Heart J 1998; 19: 1504-11
27. Ross R. Atherosclerosis, an inflammatory disease. N Engl J Med 1999; 340: 115-26
28. Tomita H, Egashira K, Kubo-Inoue M et al. Inhibition of NO synthesis induces inflammatory changes and monocyte chemoattractant protein-1 expression in rat hearts and vessels. Arterioscler Throm Vasc Biol 1998; 18: 1456-64
29. Thorne S, Mullen MJ, Clarkson P, Donald AE, Deanfield JE. Early endothelial dysfunction in adults at risk from atherosclerosis: different responses to L-arginine. J Am Coll Cardiol 1998; 32: 110-6
30. Wolfgang K, Sund M, Frohlich M et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Circulation 1999; 99: 237-42
31. Kullo IJ, Edwards WD, Schwartz RS. Vulnerable plaque: pathobiology and clinical implications. Ann Intern Med 1998; 129: 1050-60
32. Smith FB, Lowe GD, Lee AJ et al. Smoking, hemorheologic factors, and progression of peripheral arterial disease in patients with claudication. J Vasc Surg 1998; 28: 129-35
33. Casscells W, Hathorn B, David M et al. Thermal detection of cellular infiltrates in living atherosclerotic plaques: possible implications for plaque rupture and thrombosis. Lancet 1996; 347: 1447-51
34. Dreher D, Junod AF. Role of oxygen free radicals in cancer development. Eur J Cancer 1996; 32: 30-8
35. Inoue M, Osaki T, Noguchi M et al. Lung cancer patients have increased 8-hydroxydeoxyguanosine levels in peripheral lung tissue DNA. Jpn J Cancer Res 1998; 89: 691-5
36. Kadlubar FF, Anderson KE, Haussermann S et al. Comparison of DNA adduct levels associated with oxidative stress in human pancreas. Mutat Res 1998; 405: 125-33
37. Jeremy JY, Mikhailidis DP, Pittilo RM. Cigarette smoking and cardiovascular disease. J R Soc Health 1995; 115: 289-95
38. Stafford R, Becker C. Cigarette smoking and atherosclerosis. In: Fuster V, Ross R, Topol EJ (Eds) Atherosclerosis and Coronary Disease. Philadelphia, PA: Lippincott-Raven, 1996; 303-25
39. Nyyssonen K, Porkkala E, Salonen R, Korpela H, Salonen JT. Increase in oxidation resistance of athrogenic serum lipoproteins following antioxidant supplementation - a randomized double-blind placebo-controlled clinical trial. Eur J Clin Nutr 1994; 48: 633-42
40. Fruebis J, Bird DA, Pattison J, Palinski W. Extent of antioxidant protection of plasma LDL is not a predictor of the antiathrogenic effect of antioxidants. J Lipid Res 1997; 38: 2455-64
41. Pratico D, Barry OP, Lawson JA et al. IPF2α: an index of lipid peroxidation in humans. Proc Natl Acad Sci USA 1998; 95: 3449-54
42. Morrow JD, Frei B, Longmire AW et al. Increase in circulating products of lipid peroxidation (F-2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 1995; 332: 1198-203
43. Reilly M, Delanty N, Lawson JA, FitzGerald GA. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 1996; 94: 19-25
44. Miller ER, Appel LJ, Jiang L, Risby TH. Association between cigarette smoking and lipid peroxidation in a controlled feeding study. Circulation 1997; 96: 1097-101
45. Pratico D, Tangirala RK, Rader DJ, Rokach J, FitzGerald GA. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice. Nat Med 1998; 4: 1189-92
46. Celermajer DS. Noninvasive detection of atherosclerosis. N Engl J Med 1998; 339: 2014-5
47. Zieske AE, Takei H, Fallon KB, Strong JP. Smoking and atherosclerosis in youth. Arteriosclerosis 1999: 144: 403-8
48. Wissler RW, Hiltscher L, Wahend M. Early evolution of coronary artery lesions in young people: from fatty streaks to fibrous plaque-implications for imaging. In: V. Fuster, (Ed) Syndromes of Atherosclerosis: Correlations of Clinical Imaging and Pathology. Armonk, NY: Futura, 1996: 303-25
49. Galis ZS, Asanuma K, Godin D, Meng XP. N-acetyl-cysteine decreases the matrix-degrading capacity of macrophage-derived foam cells: new target for antioxidant therapy? Circulation 1998; 97: 2445-53
50. Pittilo RM, Clarke JM, Harris D et al. Cigarette smoking and platelet adhesion. Br J Haematol 1984; 58: 627-32
51. Levine GN, Frei B, Koulouris SN, Gerhard MD, Keaney Jr JF. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1996; 93: 1107-13
52. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Vitamin C improves endothelium-dependent vasodilatation by restoring nitric oxide activity in essential hypertension. Circulation 1998; 97: 2222-9
53. Hecht SS. Carcinogenic effect of cigarette smoke on the respiratory tract. In: Sipes IG, McGueen CA, Gandolfi AJ (Eds) Comprehensive Toxicology. London: Pergamon, 1997; 437-51
54. Sekido Y, Fong KM, Minna JD. Progress in understanding the molecular pathogenesis of human lung cancer. Biochim Biophys Acta 1998; 1378: F21-59
55. Wu X, Shi H, Jiang H et al. Associations between cytochrome P4502EI genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. Carcinogenesis 1997; 18: 967-73
56. Soni M, Madurantakan M, Krishnaswamy K. Glutathione S-transferase mu (GST mu) deficiency and DNA adducts in lymphocytes of smokers. Toxicology 1998; 126: 155-62
57. Benhamou S, Reinikainen M, Bouchardy C, Dayer P, Hirvonen A. Association between lung cancer and microsomal epoxide hydrolase genotypes. Cancer Res 1998; 58: 5291-3
58. Petruzzelli S, Celi A, Pulera N. Serum antibodies to benzo(a)pyrene diol epoxide-DNA adducts in the general population: effects of air pollution, tobacco smoking, and family history of lung diseases. Cancer Res 1998; 58: 4122-6
59. Lodovici M, Akpan V, Giovannini L, Migilani F, Dolara P. Benzo(a)pyrene diol-epoxide DNA adducts and levels of polycylic aromatic hydrocarbons in autoptic samples from human lungs. Chembiol Interact 1998; 116: 199-212
60. Yang K, Fang JL, Hemminki K. Abundant lipophilic DNA adducts in human tissues. Mutat Res 1998; 422: 285-95
61. Van Schooten F, Hirvonen A, Maas L. Putative susceptibility markers of coronary artery disease: association between VDR genotype, smoking, and aromatic DNA adduct levels in human right arterial tissue. FASEB J 1998; 122: 1409-17
62. Loft S, Poulsen HE. Cancer risk and oxidative DNA damage in man. J Mol Med 1996; 74: 297-312
63. Duthie SJ, Ma AG, Ross MA, Collins AR. Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes. Cancer Res 1996; 56: 1291-5
64. Prieme H, Loft S, Nyyssonen K, Salonen JT, Poulsen HE. No effect of supplementation with vitamin E, ascorbic acid, or coenzyme Q10 on oxidative DNA damage estimated by 8-oxo-7,8-dihydro-2′-deoxyguanosine excretion in smokers. Am J Clin Nutr 1997; 65: 503-7
65. Lee BM, Lee SK, Kim HS. Inhibition of oxidative DNA damage, 8-OHdG, and carbonyl contents in smokers treated with antioxidants (vitamin E, vitamin C, beta-carotene and red ginseng). Cancer Lett 1998; 132: 219-27.
66. Prieme H, Loft S, Klarlund M et al. Effect of smoking cessation on oxidative DNA modification estimated by 8-oxo-7,8-dihydro-2′-deoxyguanosine excretion. Carcinogenesis 1998; 19: 347-51
67. Wheatley C. Vitamin trials and cancer: what went wrong? J Nutr Environ Med 1998; 8: 277-88
68. Ames BN, Shigenaga MK, Hagen T. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993; 90: 7915-22
69. Greenberg ER, Baron JA, Karagas MR et al. Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation. JAMA 1996; 275: 699-703
70. Omenn GS, Goodman GE, Thornquist MD et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334: 1150-5
71. Wang XD, Liu C, Bronson RT et al. Retinoid signaling and activator protein-1 expression in ferrets given beta-carotene supplements and exposed to tobacco smoke. J Natl Cancer Inst 1999; 91: 60-6
72. Salgo MG, Cueto R, Winston GW, Pryor WA. Beta carotene and its oxidation products have different effects on microsome mediated binding of benzo[a]pyrene to DNA. Free Radic Biol Med 1999; 26: 162-73
73. Ofulue AF, Ko M, Abboud RT. Time course of neutrophil and macrophage elastinolytic activities in cigarette smoke-induced emphysema. Am J Physiol 1998; 19: L1134-44
74. Rahman I, Morrison D, Donaldson K, MacNee W. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med 1996; 154: 1055-60
75. Repine JE, Bast A, Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 156: 341-57
76. Pratico D, Basili S, Vieri M et al. Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F, alpha III, an index of oxidant stress. Am J Respir Crit Care Med 1998; 158: 1709-14
77. Ballinger SW, Bouder TG, Davis GS et al. Mitochondrial genome damage associated with cigarette smoking. Cancer Res 1996; 56: 5692-7
78. Fahn HJ, Wang LS, Kao SH et al. Smoking-associated mitochondrial DNA mutations and lipid peroxidation in human lung tissues. Am J Respir Cell Mol Biol 1998; 19: 901-909
79. Churg A, Cherukupalli K. Cigarette smoke causes rapid lipid peroxidation of rat tracheal epithelium. Int J Exp Pathol 1993; 74: 127-32
80. Carey IM, Strachan DP, Cook DG. Effects of changes in fresh fruit consumption on ventilatory function in healthy British adults. Am J Respir Cnt Care Med 1998; 158: 728-33
81. Bodner C, Giodden D, Brown K et al. Antioxidant intake and adult onset of wheeze: a case controlled study. Eur J Respir 1999; 13: 22-30
82. Sohn HO, Lim HB, Lee YG, Lee DW, Kim YT. Effect of subchronic administration of antioxidants against cigarette smoke exposure in rats. Arch Toxicol 1993; 67: 667-73
83. Hall W, Solowij N. Adverse effects of cannabis. Lancet 1998; 352: 1611-6
84. Law MR, Morris JK, Wald NJ. Environmental tobacco smoke exposure and ischemic heart disease: an evaluation of the evidence. BMJ 1997; 315: 973-80
85. Hackshaw AK, Law MR, Wald NJ. The accumulated evidence on lung cancer and environmental tobacco smoke. BMJ 1997; 315: 980-8
86. Berglund D, Abbey D, Lebowitz M, Knutsen S, McDonnell W. Respiratory symptoms and pulmonary function in an elderly nonsmoking population. Chest 1999; 115: 49-60
87. Valkonen M, Kuusi T. Passive smoking induces athrogenic changes in low-density lipoprotein. Circulation 1998; 97: 2012-6
88. Howard DJ, Ota RB, Briggs LA, Hampton M, Pritsoc CA. Environmental tobacco smoke in the workplace induces oxidative stress in employees, including increased production of 8-hydroxy-2′-deoxyguanosine. Cancer Epidomol Biomarkers Prev 1998; 7: 141-6
89. Finette BA, O'Neill JP, Vacek PM, Albertini RJ. Gene mutations with characteristic deletions in cord blood T lymphocytes associated with passive maternal exposure to tobacco smoke. Nat Med 1998; 4: 1144-51
90. Johnson GK, Payne JB, Fili JM et al. Development of smokeless tobacco-induced oral mucosal lesions. J Oral Pathol Med 1998; 27: 388-94
91. Stephens NG, Parsons A, Schofield PM et al. Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (HAOS). Lancet 1996; 347: 781-6
92. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328: 1450-6
93. Stampfer MJ, Hennekens CH, Manson JE et al. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993; 328: 1444-9
94. Davi G, Ciabattoni G, Consoli A et al. In vivo formation of 8-iso-prostaglandin F 2a and platelet activation in diabetes mellitus. Circulation 1999; 99: 224-9